PhaseBio Pharmaceuticals, Inc. Bankruptcy Docket

Cases

Plan effective Sep 30, 2024

Updated Oct 20, 4:34 AM ET

Petition filed
Oct 23, 2022
Plan confirmed
Jun 26, 2024

PhaseBio is in post-confirmation liquidation following its September 30, 2024 notice of plan effectiveness Dkt. 1171. The next milestones are the October 26, 2026 claims-objection deadline Dkt. 1277 and resolution of the trustee’s request for more time to remove litigation, with an October 28, 2026 hearing scheduled if timely objections remain unresolved under the October 1 hearing notice Dkt. 1284.

Motion2:00 PM ET

in 5 days

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

Cooley LLPBankruptcy Counsel
Richards, Layton & Finger, P.A.Bankruptcy Counsel
FTI ConsultingFinancial Advisor
Miller BuckfireInvestment Banker
SierraConstellation Partners, LLCChief Restructuring Officer

Recent activity

PhaseBio schedules hearing on amended plan confirmation
Jun 24, 2024
· pp. 1, 2, 3, 4 Dkt. 1116
PhaseBio Pharmaceuticals gets amended unsecured creditors’ committee
Sep 14, 2023
· p. 1 Dkt. 792
PhaseBio adjourns confirmation hearing to a date to be determined
Sep 12, 2023
· pp. 1, 2 Dkt. 787

Recent filings

Oct 20Order Further Extending the Period to File and Serve Objections to Claims Through and Including May 24, 2027 (Related Doc # 1283) Order Signed on 10/20/2026. (CMB) (Entered: 10/20/2026)Bankr. D. Del., No. 22-10995, ECF No. 1289View on PACERDkt. 1289
Oct 20Removal Notice Deadline ExtensionBankr. D. Del., No. 22-10995, ECF No. 1288View on PACERDkt. 1288
Oct 1Trustee Motion Re-NoticeBankr. D. Del., No. 22-10995, ECF No. 1284View on PACERDkt. 1284
Oct 1Order Scheduling Omnibus Hearings. (Related document(s)1280) Omnibus Hearings scheduled for 10/28/2026 at 02:00 PM US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #2, Wilmington, Delaware. Signed on 10/1/2026. (LJJ) (Entered: 10/01/2026)Bankr. D. Del., No. 22-10995, ECF No. 1282View on PACERDkt. 1282
May 13Order Extending Removal DeadlineBankr. D. Del., No. 22-10995, ECF No. 1279View on PACERDkt. 1279
Apr 29Order Extending Claims Objection DeadlineBankr. D. Del., No. 22-10995, ECF No. 1277View on PACERDkt. 1277

Full docket (1,459) →

Case facts and filing dates come from court records.

Plan effective Sep 30, 2024

Updated Oct 20, 4:34 AM ET

Petition filed
Oct 23, 2022
Plan confirmed
Jun 26, 2024

Motion2:00 PM ET

in 5 days

Case docket on PACER

Research this case

Search available documents for this case. Full docket access requires Pro.

Open case research

Key firms

Cooley LLPBankruptcy Counsel
Richards, Layton & Finger, P.A.Bankruptcy Counsel
FTI ConsultingFinancial Advisor
Miller BuckfireInvestment Banker
SierraConstellation Partners, LLCChief Restructuring Officer

Recent activity

PhaseBio schedules hearing on amended plan confirmation
Jun 24, 2024
· pp. 1, 2, 3, 4 Dkt. 1116
PhaseBio Pharmaceuticals gets amended unsecured creditors’ committee
Sep 14, 2023
· p. 1 Dkt. 792
PhaseBio adjourns confirmation hearing to a date to be determined
Sep 12, 2023
· pp. 1, 2 Dkt. 787

Recent filings

Oct 20Order Further Extending the Period to File and Serve Objections to Claims Through and Including May 24, 2027 (Related Doc # 1283) Order Signed on 10/20/2026. (CMB) (Entered: 10/20/2026)Bankr. D. Del., No. 22-10995, ECF No. 1289View on PACERDkt. 1289
Oct 20Removal Notice Deadline ExtensionBankr. D. Del., No. 22-10995, ECF No. 1288View on PACERDkt. 1288
Oct 1Trustee Motion Re-NoticeBankr. D. Del., No. 22-10995, ECF No. 1284View on PACERDkt. 1284
Oct 1Order Scheduling Omnibus Hearings. (Related document(s)1280) Omnibus Hearings scheduled for 10/28/2026 at 02:00 PM US Bankruptcy Court, 824 Market St., 6th Fl., Courtroom #2, Wilmington, Delaware. Signed on 10/1/2026. (LJJ) (Entered: 10/01/2026)Bankr. D. Del., No. 22-10995, ECF No. 1282View on PACERDkt. 1282
May 13Order Extending Removal DeadlineBankr. D. Del., No. 22-10995, ECF No. 1279View on PACERDkt. 1279
Apr 29Order Extending Claims Objection DeadlineBankr. D. Del., No. 22-10995, ECF No. 1277View on PACERDkt. 1277

Full docket (1,459) →

Case facts and filing dates come from court records.

PhaseBio Pharmaceuticals, Inc.

Plan effective Sep 30, 2024

Research this case

Key firms

Recent activity

PhaseBio schedules hearing on amended plan confirmation

PhaseBio Pharmaceuticals gets amended unsecured creditors’ committee

PhaseBio adjourns confirmation hearing to a date to be determined

Recent filings

Plan effective Sep 30, 2024

Research this case

Key firms

Recent activity

PhaseBio schedules hearing on amended plan confirmation

PhaseBio Pharmaceuticals gets amended unsecured creditors’ committee

PhaseBio adjourns confirmation hearing to a date to be determined

Recent filings

PhaseBio Pharmaceuticals, Inc.

PhaseBio Pharmaceuticals, Inc.

PhaseBio Pharmaceuticals, Inc.

Plan effective Sep 30, 2024

Research this case

Key firms

Recent activity

PhaseBio schedules hearing on amended plan confirmation

PhaseBio Pharmaceuticals gets amended unsecured creditors’ committee

PhaseBio adjourns confirmation hearing to a date to be determined

Recent filings